No Detail Found!

Serum Wnt10B/²-Catenin in Early Diagnosis, Lymph Node Metastasis, and Prognosis in Cervical Cancer

Author(s)
Jingyun Wang Department of Gynaecology, Hunan Provincial People’s Hospital, The First Hospital Affiliated with Hunan Normal University, Hunan, China
Yahong Wu Department of Gynaecology, Hunan Provincial People’s Hospital, The First Hospital Affiliated with Hunan Normal University, Hunan, China
Abstract
Objective: To assess the serum levels of Wnt10B and ²-catenin for early diagnosis of the cervical cancer and their association with distant lymph node metastasis and prognosis. Study Design: Observational study. Place and Duration of the Study: Department of Gynaecology, Hunan Provincial People s Hospital,The First Hospital A liated with Hunan Normal University, Changsha, Hunan, China, from September 2019 to 2023. Methodology: The cervical cancer group included 156 patients, while the control group comprised 96 healthy women. Serum samples were collected to compare the levels of²-catenin and Wnt10B. Univariate and multivariate analyses were used to explore the relationship between these biomarkers and clinical characteristics. The receiver Operating Characteristic (ROC) curve analysis was conducted to evaluate their diagnostic value. Results: The cervical cancer group exhibited signi cantly higher serum levels of²-catenin and Wnt10B compared to the control group (p <0.001). Univariate analysis revealed markedly elevated levels ofWnt10B and ²-catenin (p <0.001) in patients with poor prognosis, lymph node metastasis, and advanced stages (III IV). Multivariate analysis identi ed prognosis (p = 0.02) and lymph node metastasis (p <0.001) as independent risk factors for elevated Wnt10B and prognosis (p = 0.006) as a risk factor for increased ²-catenin . According to ROC curve analysis, serum levels of Wnt10B (AUC = 0.77, p = 0.0003), ²-catenin (AUC = 0.73, p = 0.0021), and the combined diagnostic approach (AUC = 0.79, p = 0.0001) could be used to predict the risk of postoperative recurrence. Conclusion: Serum levels of Wnt10B and ²-catenin are valuable biomarkers for early cervical cancer diagnosis, lymph node metastasis, and prognosis of cervical cancer.
Publication Details
Page(s) 318-323
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 35, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Cervical Cancer, prognosis, Early diagnosis, Prognostic biomarkers, ²-catenin, Wnt10B
References
Arbyn M,Weiderpass E,Bruni L,de Sanjose S,Saraiya M,Ferlay J .2020 .Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis. Lancet Glob Health, 10(19) : 30482-6.
Sharma S,Deep A,Sharma AK . .Current treatment for cervical cancer: An update. Anticancer Agents Med Chem, : .
Li C,Chen X,Liu T,Chen G. lncRNA .2020 .HOTAIRM1 regulates cell proliferation and the metastasis of thyroid cancer by targeting Wnt10B. Oncol Rep, 7919(3) : 1083-93.
Wang B,Li X,Liu L,Wang M .2020 .Beta-catenin: Oncogenic role and therapeutic target in cervical cancer. Biol Res, 10(1) : 33.
Zhang X,Zeng Q,Cai W,Ruan W. .2021 .Trends of cervical cancer at global, regional, and national level: Data from the global burden of disease study 2019. BMC Public Health, 10(1) : 894.
.2022 .One-dose human papillomavirus (HPV) vaccine o ers solid protection against cervical cancer. Saudi Med J, 43(5) : 538.
Boni S,Tchounga B,Comoe K,Guie P,Adie M,Horo A .2019 .Assessment of the scale-up of cervical cancer screening in Abidjan strati ed by HIV status. Int J Gynaecol Obstet, 10(2) : 246-51.
Canfell K. Towards .2019 .the global elimination of cervical cancer. Papillomavirus Res, 100170 : 100170.
Brisson M,Drolet M. .2019 .Global elimination of cervical cancer as a public health problem. Lancet Oncol, 19(3) : 30072-5.
Rajaram S,Gupta B .2021 .Screening for cervical cancer: Choices and dilemmas. Indian J Med Res, 857(2) : 20-20.
Si J,Zhang J,Gan L,Guo M,Xie Y .2020 .The e ects of the Wnt/beta catenin signaling pathway on apoptosis in HeLa cells induced by carbon ion irradiation. Oncol Rep, 7581(1) : 303-12.
Yang M,Wang M,Li X,Xie Y,Xia X,Tian J .2018 .. Wnt signaling in cervical cancer? J Cancer, 10(7) : 1277-86.
Lee FS,Lane TF,Kuo A,Shackleford GM,Leder P .1995 .Insertional mutagenesis identi es a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice. Proc Natl Acad Sci U S A, 10(6) : 2268-72.
Song H,Qiu J,Hua K. .2024 .USP14 promotes the proliferation of cervical cancer via upregulating beta-catenin. Environ Toxicol, 10(2) : 1031-43.
Yang Q,Zhao Y,Chen Y,Chang Y,Huang A,Xu T .2020 .PAK6 promotes cervical cancer progression through activation of the Wnt/beta-catenin signaling pathway. Oncol Lett, 11797(3) : 2387-95.
Zheng J,Yu J,Yang M,Tang L M .2019 .Ge tinib suppresses cervical cancer progression by inhibiting cell cycle progression and epithelial-mesenchymal transition. Exp Ther Med, 7754(3) : 1823-30.
Yang T,Tian S,Wang L,Wang Y,Zhao J .2020 .-3p overexpression represses the proliferation and invasion of cervical cancer cells through downregulation of SPAG5-mediated Wnt/beta-catenin signalling. Clin Exp Pharmacol Physiol, 10(4) : 13222-1681.
Lin R,Hu X,Chen S,Shi Q,Chen H .2020 .Naringin induces endoplasmic reticulum stress-mediated apoptosis, inhibits betacatenin pathway and arrests cell cycle in cervical cancer cells. Acta Biochim Pol, 5182(2) : 181-8.
Gu J,Zhang X,Yang Z,Wang N. .2019 .Expression of cyclin D1 protein isoforms and its prognostic signi cance in cervical cancer. Cancer Manag Res, 10 : 9073-83.
Zhang J,Shen Q,Xia L,Zhu X,Zhu X. .2022 .DYNLT3 overexpression induces apoptosis and inhibits cell growth and migration via inhibition of the Wnt pathway and EMT in cervical cancer. Front Oncol, 889238 : 889238.
0

Citations

0

Downloads

50

Views